The global blood glucose monitoring system market was at a net worth of $14.79B in 2021 and is projected to grow at a CAGR of 10.12% between 2022-2028 and reach a market value of $31.5B during the forecast period.
Industry Prospective:
The global blood glucose monitoring system market was at a net worth of $14.79B in 2021 and is projected to grow at a CAGR of 10.12% between 2022-2028 and reach a market value of $31.5B during the forecast period. The report analyzes the blood glucose monitoring system's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global blood glucose monitoring system market.
Blood Glucose Monitoring System Market: Overview
A blood glucose monitoring system also known as BGM is an effective tool used for monitoring blood sugar levels, especially for diabetic patients. Blood glucose monitoring systems have helped patients become self-reliant and take control of their medical health. BGM systems track high or low glucose levels and encourage the patients to take relevant medication or treatment.
BGM systems work by understanding the resistance to an electric current sent through a blood-stained test strip. Or by inserting a sensor under the patient's skin that reads the glucose level between cell fluids.
The type of blood glucose monitoring system to be used depends on the requirements of the patient. Multiple options for BGM devices are present in the market catering to the different medical needs.
The global blood glucose monitoring system is witnessing a surge in its global market value and is projected to touch milestones during the forecast period.
Blood Glucose Monitoring System Market: Growth Drivers
Increasing population of diabetic patients to drive global market growth
The number of patients worldwide suffering from type 1 and type 2 diabetes has grown exponentially over the last couple of years. The changing stationary lifestyle, poor eating habits, and genetic disorders are the leading cause of growth in diabetic patients. This rising insulin dependency is expected to propel the global blood glucose monitoring system market towards growth in the forecast period.
In 2021, International Diabetes Federation published a report, the findings of which stated that around 537M of the population in countries like India, Mexico, and China suffer from diabetes.
The presence of multiple manufacturers of blood glucose monitoring systems offering technically advanced devices at favorable prices is anticipated to contribute to the global market growth during the forecast period.
Developed economies having state-of-the-art medical facilities are expected to fuel the global market growth.
Blood Glucose Monitoring System Market: Restraints
Lack of awareness along with the high cost of devices in emerging economies to restrain the global market
A fair share of the population in growing economies is unaware of diabetes and its management. Furthermore, developing economies lack the necessary infrastructure for treatment facilities to manage chronic diseases like diabetes. The lack of awareness and absence of advanced medical facilities is expected to hamper the blood glucose monitoring system market during the forecast period.
Emerging economies are also lagging in the necessary funding required for R&D which restricts the global market growth.
SMBG and CGM are invasive techniques. Patients’ hesitancy while using the invasive methods for tracking diabetes is projected to restrict the global market growth.
Blood Glucose Monitoring System Market: Opportunities
Explosive amount of untapped market to provide growth opportunities in the global market
As per IDF's 2021 report, half of the total diabetic patients have remained undiagnosed in Africa. Around 56% of the Asia-Pacific population comprises undiagnosed patients. This provides a massive opportunity for global market leaders to tap into.
The country governments have been taking proactive actions, conducting programs to educate the masses about diabetes and ways to control it. The global blood glucose monitoring system market can bank upon these initiatives to provide growth opportunities in the forecast period.
Blood Glucose Monitoring System Market: Challenges
Lack of funding to present a challenge for the global market growth
Lack of funding for technical advancement in the field of blood glucose monitoring systems poses a major challenge in the global market during the forecast period. Developed countries have shown more acceptance towards the BGM devices owing to better awareness and technically rich devices However, developing economies need more investment to penetrate every corner of the target global market.
For developing nations, the prices of BGM devices can be relatively higher than in developed nations. The maintenance and supporting accessories increase the overall cost of the device making it less cost-effective for patients in these territories. This is a major challenge for the global market to tackle.
Diabetes is one of the few medical conditions which are not reimbursed by healthcare agencies. The absence of reimbursement, particularly in SMBG, challenges the upward global market growth. Since the disease is not reimbursed, a potential number of patients fail to get themselves tested for diabetes and a huge chunk of the global market remains in isolation.
Blood Glucose Monitoring System Market: Segmentation
The global blood glucose monitoring system is segmented based on product, testing site, indication, end-user, and region.
Based on product, the global market is segmented between self-monitoring and continuous glucose monitoring devices. SBGM is expected to maintain the highest share in the global market owing to its cost-effectiveness and hassle-free usage.
Based on testing sites, the global market is segmented between fingertip testing and alternate site testing. Fingertip testing is anticipated to cover the market share more than alternate site testing during the forecast period.
Based on indication, the global market is segmented between type-I diabetes, type-II diabetes, and others. As of 2021, the global market share was dominated by type-II diabetic patients because of more patients suffering from type-II diabetic conditions.
Based on end-user, the global market is segmented by hospitals, clinics, and homecare. In 2021, the hospital segment marked the highest revenue and is anticipated to lead the global market during the forecast part owing to heavy investments in the hospital segment.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Recent Developments:
Blood Glucose Monitoring System Market: Regional landscape
The global market is likely to be led by North America during the forecast period
North America was attributed with the highest global blood glucose monitoring system market in 2021 owing to a 35.5% share of the global revenue. Prevalence of obesity in addition to the high standard of medical assistance provided to patients, technically advanced equipment is expected to assist North America in staying the highest revenue contributor during the forecast period.
Europe shares a significant amount of global market share because of the awareness and proactive approach of their population in diagnosing and managing diabetes. Europe is expected to continue its growth streak because of the intense investment in healthcare facilities.
Asia Pacific is anticipated to register a higher CAGR during the forecast period owing to growing awareness & acceptance of BGM systems, particularly in India & China. The increase in investments in medical facilities is also a major cause for the anticipated growth. The slow but steady growth in spending capability of the general population is another factor expected to contribute to the global market.
The Middle East, Latin America & Africa are expected to show slow growth majorly because of a lack of awareness amongst the population about proper diabetes management. The number of undiagnosed patients in these regions still remains high causing a lagging growth graph in the global market. Below par standard of living is also one of the causes of registering slower CAGR.
Blood Glucose Monitoring System Market: Competitive Analysis
The global blood glucose monitoring system market is dominated by leaders like Glysens Incorporated, Lifescan IP Holdings, Senseonics, Prodigy Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ACON Laboratories, Medtronic, F.Hoffmann-la Roche, Sanofi, Dexcom Inc, Novo Nordisk, Insulet Corporation, Ascensia Diabetes Care, Ypsomed Holdings, Nova Biomedical.
The global blood glucose monitoring system market is segmented as follows:
By Product:
By Testing Site:
By Indication:
By End-User
By Region
Blood glucose monitoring devices are used to detect the glucose level in the blood. Glucose is a type of sugar present at a certain level in a human body. When this glucose level drops, a person suffers from diabetes. Blood glucose monitoring devices are used to monitor the glucose levels of diabetic patients.
The occurrence of diabetes is increasing at an exponential pace worldwide and has become one of the serious health concerns. WHO (World Health Organization) declared it a global epidemic due to its rapidly increasing prevalence. Approximately 30.3 million, i.e., 9.4% of the U.S. population is suffering from diabetes. The global incidence of diabetes has risen from 4.7% to 8.5%, i.e., doubled since the 1980s in adults. Increased prevalence of diabetes is mainly driving the growth of the blood glucose monitoring system market. Additionally, the increase in adoption of sugar surveillance system, increase in adoption of minimally invasive techniques, growing the aging population, technological advancements in the blood glucose monitoring systems, and rising awareness about the use of these systems in developing regions is anticipated to fuel the growth of the global blood glucose monitoring system market.
The blood glucose monitoring system market is segmented on the basis of product type, testing site, indication, and end-user. Based on product type, the market for the blood glucose monitoring system is further segmented into self-monitoring devices and continuous glucose monitoring devices. Self-monitoring devices segment is further sub-segmented into blood glucose meters, lancets & lancets devices, and testing strips. The self-monitoring devices segment is dominating the global market for blood glucose monitoring system, owing to the rapid product development. On the basis of testing site, this market is further segmented into fingertip testing and alternate testing site. Fingertip testing is anticipated to dominate the market due to its accuracy. Based on the indication, the blood glucose monitoring system market is segmented into type-I diabetes, type-II diabetes, and gestational diabetes. Type-I and type-II diabetes are further sub-segmented into adult and pediatrics. Type-II diabetes segment is anticipated to dominate the application segment of blood glucose monitoring devices, due to the increase in the prevalence of this diabetes type. The end-user segment includes hospitals, clinics, and homecare. Homecare segment is anticipated to dominate the market.
North America is anticipated to dominate the market in the forecast period, due to rise in the initiatives undertaken by the government for prevention and treatment of diabetes with the help of leading players of the region, the rapid use of well-developed technology, and increase in R&D activities. The Asia Pacific is expected to show the highest growth due to an increase in the population suffering from diabetes. The increase in the aging population, lifestyle-associated changes, rising awareness regarding diabetes, and rapid urbanization are some of the factors fueling the growth of the blood glucose monitoring system market in the Asia Pacific region.
The key players operating in the global blood glucose monitoring system market are Abbott Laboratories, Novo Nordisk A/S, Hoffmann-La Roche Ltd., Sanofi, Medtronic, Nova Biomedical, B. Braun Melsungen, Terumo Corporation, ARKRAY Inc., and Becton, Dickinson, and Company. These companies focus on developing new technologies and getting it FDA approved so that they can launch it. For instance, in 2018, Medtronic received approval from FDA for smart continuous glucose monitor. In 2017, Abbott received approval from FDA for the first continuous glucose monitoring system that does not require blood sample calibration.
Request the coronavirus impact analysis across industries and markets
The number of patients worldwide suffering from type 1 and type 2 diabetes has grown exponentially over the last couple of years. This rising insulin dependency is expected to propel the global market towards growth in the forecast period. The presence of multiple manufacturers of blood glucose monitoring systems offering technically advanced devices at favorable prices is anticipated to contribute to the global market growth during the forecast period. The developed economies having state-of-the-art medical facilities are expected to fuel the global market.
According to Zion Market Research, the global blood glucose monitoring system was at a net worth of $14.79B in 2021 and is projected to grow at a CAGR of 10.12% between 2022-2028 & reach a market value of $31.5B during the forecast period
North America was attributed with the highest global blood glucose monitoring system market in 2021 owing to a 35.5% share of the global revenue. It is expected to follow the growing trend during the forecast period. North America is followed by Europe owing to the awareness and proactive approach of their population in diagnosing and managing diabetes Asia-Pacific is anticipated to register a higher CAGR during the forecast period because of rising acceptance of BGM devices and growing standard of living. The Middle East, Latin America & Africa are expected to show steady growth majorly because of a lack of awareness amongst the population about proper diabetes management.
The global blood glucose monitoring system market is dominated by leaders like Glysens Incorporated, Lifescan IP Holdings, Senseonics, Prodigy Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ACON Laboratories, Medtronic, F.Hoffmann-la Roche, Sanofi, Dexcom Inc, Novo Nordisk, Insulet Corporation, Ascensia Diabetes Care, Ypsomed Holdings, Nova Biomedical.
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed